The University of Chicago and healthcare investment firm Deerfield Management announced today the launch of Hyde Park Discovery, a collaboration aiming to advance the development of new medicines and ...

Shares of Suven Life Sciences are higher by more than ... I6107 being conducted in USA under FDA acceptance of Investigational New Drug (IND) and issue of Study May Proceed letter," said the ...

The US Food and Drug Administration (FDA) recently issued its draft guidance, Considerations for the Use of Artificial Intelligence to ...

The FDA's above-mentioned designation is intended to expedite the development and review of therapeutic drugs being evaluated for the treatment of serious or life-threatening conditions.

Its truly unique Acolyte Image-Guided Crossing and Re-Entry Catheter System has been granted an Investigational Device Exemption ... from US FDA and was accepted into the Total Product Life Cycle ...

This is not how Intellia would have wanted to kick off its J.P. Morgan Healthcare Conference news cycle. The CRISPR company, once at the cutting edge of new life sciences research, is waving ...

Results from the investigational, randomized ... including very good partial response (VGPR), incidence rate of infusion reactions and C trough at cycle 2 were also achieved. The study is ongoing, and ...

The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, ...

The enFuse OBDS enables high-volume subcutaneous drug delivery, potentially reducing healthcare ... Sarclisa was administered subcutaneously via an on-body delivery system (OBDS) in the ...

In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...